We are in the process of finalising our 2019 programme which can be found below.
Please note : The information shown on this page is still in draft form and will be updated as our programme develops.
Monday 9th December 2019
| 18:00 | - | 20:00 | Welcome drinks reception & registration
|
Tuesday 10th December 2019
| 9:00 | - | 10:15 | Welcome address and keynote lecture
PresentationsWhen being a scientist is not enough Mayana Zatz - Professor of Genetics, University of São Paulo, Brazil |
| 10:15 | - | 10:45 | Coffee break
|
| 10:45 | - | 12:15 | Patient engagement
Chaired by :
Fabiola Bertinotti – Patient representative, Italy
Ria Broekgaarden – Netherlands
PresentationsPatient advocacy Ingrid de Groot - Patient representative, The NetherlandsSession One: Presentation Two - , |
| 12:15 | - | 14:00 | Lunch break
|
| 14:00 | - | 15:30 | Adults with progressive neuromuscular disease
Chaired by :
Anri Human – Sefako Makgatho Health Sciences University, South Africa
Zohar Argov – Hadassah University Hospital, Israel
PresentationsRespiratory Muscle Training Anri Human - Sefako Makgatho Health Sciences University, South AfricaNutritional assessment and interventions in adult NMD Heidi Zweers - Radbound University Nijmegen Medical Centre, NetherlandsExercise in neuromuscular disease: a moving topic Nicole Voet - Radbound University Medical Center, NetherlandsThis session with close with a panel discussion and questions. |
| 15:30 | - | 16:00 | Coffee break & posters
|
| 16:00 | - | 17:30 | New technologies & platforms
Chaired by :
Jordi Díaz-Manera – Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
Volker Straub – John Walton Muscular Dystrophy Research Centre, Newcastle University, UK
PresentationsDeep learning and imaging recognition Jordi Díaz-Manera - Hospital de la Santa Creu I Sant Pau, Barcelona, SpainSupporting the collection of post-marketing surveillance data Craig Campbell - Western University, CanadaThe EURO-NMD Clinical Patient Management System (CPMS) Teresinha Evangelista - Researcher and EURO-NMD Coordinator, INSERM Institute of myology, FranceThis sessions will clode with a panel discussion and questions |
| 19:30 | - | 23:00 | Networking dinner
|
Wednesday 11th December 2019
| 9:00 | - | 10:30 | Personalised medicine
Chaired by :
Annemieke Aartsma-Rus – Leiden University Medical Center, Netherlands
Volker Straub – John Walton Muscular Dystrophy Research Centre, Newcastle University, UK
PresentationsCase study of personalized medicine - , CRISPR-Based Genome Editing for Duchenne Muscular Dystrophy – Successes Charles Gersbach - Duke University, Durham NC, United StatesCRISPR-Based Genome Editing for Duchenne Muscular Dystrophy – Challenges Annemieke Aartsma-Rus - Leiden University Medical Center, NetherlandsPanel discussion and questions |
| 10:30 | - | 11:00 | Coffee break
|
| 11:00 | - | 12:30 | Access to drug treatment
Chaired by :
Ans van der Ploeg – Netherlands
Ria Broekgaarden – Netherlands
PresentationsSession Five: Presentation One - , Session Five: Presentation Two - , Session Five: Presentation Three - , Panel discussion and questions |
| 12:30 | - | 14:00 | Lunch break
|
| 14:00 | - | 15:30 | Pregnancy in neuromuscular disorders
Chaired by :
Sabine Rudnik-Schöneborn – Medical University of Innsbruck, Austria
Zohar Argov – Hadassah University Hospital, Israel
PresentationsFrequent questions raised by patients before pregnancy Zohar Argov - Hadassah University Hospital, IsraelPersonal experience of pregnancy with progressive myopathy Yuriko Oda - Patient Association for Distal Myopathies (PADM), JapanLessons learned from pregnancies in myotonic dystrophies Sabine Rudnik-Schöneborn - Medical University of Innsbruck, AustriaPanel discussion and questions |
| 15:30 | - | 16:00 | Coffee break
|
| 16:00 | - | 17:30 | Learning from successes of clinical trials
Chaired by :
Linda Lowes –
Stojan Peric – Neurology Clinic, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Serbia
PresentationsLearning from CMT trials in adults and children David Cornblath - Johns Hopkins University School of Medicine, USAChallenges and limitations of re-using outcome measures and trial design Lindsay Alfano - Nationwide Children’s Hospital, USAPatient reported outcome measures in neuromuscular diseases: obstacles and perspectives Stojan Peric - Neurology Clinic, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, SerbiaPanel discussion and questions |
| 17:30 | - | 18:00 | Close of meeting
|
